Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis
Tóm tắt
Conventional brain and spinal cord magnetic resonance images were performed in 21 patients with human T-cell lymphotropic virus (HTLV)-1 associated myelopathy/tropical spastic paraparesis, to assess the role of conventional magnetic resonance imaging (MRI) in the disease diagnosis. These patients had no other central nervous system conditions or related risk factors at the time of tropical spastic paraparesis diagnosis. Eleven (52.4%) patients showed nonspecific brain abnormalities on T2-weighted images. The majority (77.2%) of brain abnormalities were located in the deep white matter. A transient contrast-enhancing lesion was identified in the brain of only one patient. In the brain of another patient, 9.0% of the T2-hyperintense lesion load was hypointense on the correspondent T1-weighted images. No differences in terms of demographic, biological, or clinical variables were present between patients with abnormal brain images and those with normal brain magnetic resonance images. Spinal cord T2-weighted images were abnormal in three (14.3%) patients. In one of these three patients, a diffuse but transient edema was found along the entire tract of the spinal cord. White matter lesions were present in the central nervous system of 60% of the cases in this study. However, no correlations between magnetic resonance imaging and clinical findings, and no specificity of lesions were observed. Hence, conventional magnetic resonance imaging is a sensitive but not highly specific tool for diagnosis of tropical spastic paraparesis.
Tài liệu tham khảo
Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, Yamanaka H, Isashiki Y, Osame M, Izumo S (2000). Histopathological analysis of four autopsy cases of HTLV-1-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol (Berl) 100: 245–252.
Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, Frank JA (2003). Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 126: 1782–1789.
Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H (2001). Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783–793.
Cartier LM, Cea JG, Vergara C, Araya F, Born P (1997). Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system. J Neuropathol Exp Neurol 56: 403–413.
Cruickshank JK, Rudge P, Dalgleish AG, Newton M, McLean BN, Barnard RO, Kendall BE, Miller DH (1989). Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain 112: 1057–1090.
Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH (1999). The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 53: 448–456.
Fukushima T, Ikeda T, Uyama E, Uchino M, Okabe H, Ando M (1994). Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM). J Neurol Sci 126: 30–39.
Furukawa Y, Bangham CR, Taylor GP, Weber JN, Osame M (2000). Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Clin Exp Immunol 120: 307–316.
Gasperini C, Rovaris M, Sormani MP, Bastianello S, Pozzilli C, Comi G, Filippi M (2001). Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis. Mult Scler 7: 27–31.
Gessain A, Gout O (1992). Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 117: 933–946.
Godoy AJ, Kira J, Hasuo K, Goto I (1995). Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semi-quantitative MRI study. J Neurol Sci 133: 102–111.
Jacobson S (2002). Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186: S187-S192.
Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245–248.
Jenkinson M, Smith S (2001). A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143–156.
Jernigan M, Morcos Y, Lee SM, Dohan FC, Raine C, Levin MC (2003). IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology 60: 1320–1327.
Hickman SJ, Miller DH (2000). Imaging of the spine in multiple sclerosis. Neuroimaging Clin N Am 10: 689–704.
Howard AK, Li DK, Oger J (2003). MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives. Can J Neurol Sci 30: 41–48.
Kasahata N, Shiota J, Miyazawa Y, Nakano I, Murayama S (2003). Acute human T-lymphotropic virus type 1-associated myelopathy: a clinicopathologic study. Arch Neurol 60: 873–876.
Kermode AG, Rudge P, Thompson AJ, du Boulay EP, McDonald WI (1990). MRI of thoracic cord in tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 53: 1110–1111.
Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K (1991). Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 106: 41–49.
Kira J, Minato S, Itoyama Y, Goto I, Kato M, Hasuo K (1988). Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data. J Neurol Sci 87: 221–232.
Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M (1994). HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 53: 23–29.
Kuroda Y, Matsui M, Yukitake M, Kurohara K, Takashima H, Takashima Y, Endo C, Kato A, Mihara F (1995). Assessment of MRI criteria for MS in Japanese MS and HAM/TSP. Neurology 45: 30–33.
Kurtzke JF (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452.
Levin MC, Jacobson S (1997). HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J NeuroVirol; 3: 126–140.
Levin MC, Lehky TJ, Flerlage AN, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S (1997). Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med 336: 839–845.
Melo A, Moura L, Rios S, Machado M, Costa G (1993). Magnetic resonance imaging in HTLV-I associated myelopathy. Arq Neuropsiquiatr 51: 329–332.
Milagres AC, Jorge ML, Marchiori PE, Segurado AA (2002). Human T cell lymphotropic virus type 1-associated myelopathy in Sao Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort. Neuroepidemiology 21: 153–158.
Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M, Haase AT (1996). Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 84–90.
Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S (2001). Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 183: 197–205.
Nakagawa M, Izumo S, Ijichi S, et al (1995). HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol 1: 50–61.
Ogata A, Nagashima K, Tashiro K, Miyakawa A, Mikuni C (1993). MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry 56: 194–196.
Osame M (1990). Review of WHO Kagoshima Meeting and Diagnostic guidelines for HAM/TSP. In: Human retrovirology: HTLV, 1st ed. Blattner WA (ed). New York: Raven Press, pp 191–197.
Roman GC, Roman LN. Tropical spastic paraparesis (1988). A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome. J Neurol Sci 87: 121–138.
Rudge P, Ali A, Cruickshank JK (1991). Multiple sclerosis, tropical spastic paraparesis and HTLV-1 infection in Afro-Caribbean patients in the United Kingdom. J Neurol Neurosurg Psychiatry 54: 689–694.
Shakudo M, Inoue Y, Tsutada T (1999). HTLV-I-associated myelopathy: acute progression and atypical MR findings. AJNR Am J Neuroradiol 20: 1417–1421.
Smith CR, Dickson D, Samkoff L (1992). Recurrent encephalopathy and seizures in a US native with HTLV-I-associated myelopathy/tropical spastic paraparesis: a clinicopathologic study. Neurology 42: 658–661.
Tajima Y, Kishimoto R, Sudoh K, Miyazaki Y, Kikuchi S, Tashiro K (2003). Spinal Magnetic Resonance Image alterations in human T-lymphotropic virus type I-associated myelopathy patients before and after immunomodulating treatments. J Neurol 250: 750–753.
Watanabe M, Yamashita T, Hara A, Murakami T, Ando Y, Uyama E, Mita S, Uchino M (2001). High signal in the spinal cord on T2-weighted images in rapidly progressive tropical spastic paraparesis. Neuroradiology 43: 231–233.
Yanagihara C, Nakaji K, Nishimura Y (2000). A case of HTLV-I associated myelopathy with abnormal patchy MRI lesions in the spinal cord. Rinsho Shinkeigaku 40: 254–258.
Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M (1994). Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 53: 72–77.